103
Views
6
CrossRef citations to date
0
Altmetric
Original Articles

Prognostic utility of serum YKL-40 in patients with cervical cancer

, , , , & ORCID Icon
Pages 687-693 | Received 12 May 2020, Accepted 01 Nov 2020, Published online: 13 Nov 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Yi-Ding Chen, Ci-You Huang, Zhuo-Ping Wang & Wen Wang. (2023) Increased YKL-40 levels are linked with disease severity of initially diagnosed Graves’ disease. Libyan Journal of Medicine 18:1.
Read now
Medi Kori & Kazim Yalcin Arga. (2022) Human oncogenic viruses: an overview of protein biomarkers in viral cancers and their potential use in clinics. Expert Review of Anticancer Therapy 22:11, pages 1211-1224.
Read now

Articles from other publishers (4)

Yu‐Ching Wen, Chia‐Yen Lin, Kuo‐Hao Ho, Yung‐Wei Lin, Chi‐Hao Hsiao, Shian‐Shiang Wang, Lun‐Ching Chang, Shun‐Fa Yang & Ming‐Hsien Chien. (2023) Functional variants of the chitinase 3‐like 1 gene are associated with clinicopathologic outcomes and progression of prostate cancer . Journal of Cellular and Molecular Medicine.
Crossref
Kazim Yalcin Arga & Medi Kori. 2023. Oncogenic Viruses. Oncogenic Viruses 221 252 .
Yanzi Qin & Wenjun Zhao. (2022) The Modeling Analysis and Effect of CHI3L1 and CD31-Marked Microvessel Density in the Occurrence and Development of Cervical Squamous Cell Carcinoma. Computational and Mathematical Methods in Medicine 2022, pages 1-9.
Crossref
R. K. Minyazeva, G. Y. Battalova, I. V. Sakhautdinova & I. R. Gilyazova. (2021) Genomic and Proteomic Markers of Cervical Cancer: a Prospective Outlook. Creative surgery and oncology 11:2, pages 166-173.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.